2022
DOI: 10.3389/fonc.2022.887068
|View full text |Cite|
|
Sign up to set email alerts
|

ITGB5 promotes innate radiation resistance in pancreatic adenocarcinoma by promoting DNA damage repair and the MEK/ERK signaling pathway

Abstract: Pancreatic adenocarcinoma (PAAD) is one of the most aggressive digestive system tumors in the world, with a low early diagnosis rate and a high mortality. Integrin beta 5 (ITGB5) is demonstrated to be a potent tumor promoter in several carcinomas. However, it is unknown whether ITGB5 participates in the occurrence and development of PAAD. In this study, we confirmed a high expression of ITGB5 in PAAD and its role in promoting invasiveness and transitivity in PAAD. Besides, the knockdown of ITGB5 increased cell… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 50 publications
0
3
0
Order By: Relevance
“…Previous studies showed that ITGB5 contributes to the resistance to radio-and chemotherapy [38] and also affect EMT and tumor growth in carcinoma cells [39]. Its overexpression is associated with the activation of survival signaling cascades [40], enhanced adhesion and motility [41], preserved stem cell-like traits [42], suppressed anti-tumor immunity [43], and stimulated angiogenesis [42]. These mechanisms collectively suggest mitigation of apoptosis, promotion of invasion and metastasis, conservation of drug-resistant subpopulations, suppression of immunologic cytotoxicity, reduction of intracellular chemotherapy concentrations, and enhancement of vascularization, thus countering TDM-1 treatment.…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies showed that ITGB5 contributes to the resistance to radio-and chemotherapy [38] and also affect EMT and tumor growth in carcinoma cells [39]. Its overexpression is associated with the activation of survival signaling cascades [40], enhanced adhesion and motility [41], preserved stem cell-like traits [42], suppressed anti-tumor immunity [43], and stimulated angiogenesis [42]. These mechanisms collectively suggest mitigation of apoptosis, promotion of invasion and metastasis, conservation of drug-resistant subpopulations, suppression of immunologic cytotoxicity, reduction of intracellular chemotherapy concentrations, and enhancement of vascularization, thus countering TDM-1 treatment.…”
Section: Discussionmentioning
confidence: 99%
“…Metabolic reprogramming also contributes to radiation resistance in PDAC. Overexpression of Mucin1 (Muc1) in PDAC cells can mitigate radiationinduced cytotoxicity by enhancing glycolysis, the pentose phosphate pathway, and nucleotide biosynthesis [24][25][26][27].…”
Section: Reversing Radiation Resistance Naturementioning
confidence: 99%
“…The various phospho-proteins in this pathway are activated under assorted stressors, such as UV or ionizing radiation exposure, and play a role in the transcription of genes defining cell fate. For example, the MEK/ERK pathway has been shown to contribute to an anti-apoptotic pathway following radiation, providing cells with radioresistance [6,7]. ERK activation has been shown to trigger cell proliferation and to provide a survival advantage [8,9], although it has also been known to promote cell death under other conditions, depending upon its location and the extent of activation [10].…”
Section: Introductionmentioning
confidence: 99%